Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89.9M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
45.5M
-
Shares change
-
-424K
-
Total reported value, excl. options
-
$625M
-
Value change
-
-$7.33M
-
Put/Call ratio
-
0
-
Number of buys
-
73
-
Number of sells
-
-40
-
Price
-
$13.73
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2023
140 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q1 2023.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.5M shares
of 89.9M outstanding shares and own 50.63% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (3.67M shares), Logos Global Management LP (3.6M shares), BlackRock Inc. (3.55M shares), FEDERATED HERMES, INC. (2.86M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.68M shares), Canaan Partners X LLC (2.66M shares), BVF INC/IL (2.46M shares), VANGUARD GROUP INC (2.32M shares), Boxer Capital, LLC (2.2M shares), and STATE STREET CORP (2.11M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.